A recent study found that carrimycin significantly improved immune function and reduced disease severity in patients with tumors who have sepsis, highlighting its potential as an effective immune-modulating...
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
An international task force of 35 pediatric experts developed and validated new criteria for sepsis and septic shock in children and adolescents based on a large international database and a systematic...
Researchers sought to determine whether adults hospitalized for sepsis are at an increased risk of death or rehospitalization for cardiovascular events.
Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.
In the United States, the prevalence of Lyme disease cases continues to grow in certain parts of the country causing an increased public health concern.
The Infectious Diseases Society of America has published treatment guidance on 3 of the most common drug-resistant pathogens: AmpC b-lactamase producing Enterobacterales, Carbapenem-resistant Acinetobacter...
To determine the in-vitro susceptibilities of delafloxacin and the comparator quinolones, the researchers tested clinical isolates from patients with community-acquired pneumonia and lower respiratory tract...
